286 related articles for article (PubMed ID: 11091847)
21. EBV and Apoptosis: The Viral Master Regulator of Cell Fate?
Fitzsimmons L; Kelly GL
Viruses; 2017 Nov; 9(11):. PubMed ID: 29137176
[TBL] [Abstract][Full Text] [Related]
22. The Epstein-Barr virus encoded BART miRNAs potentiate tumor growth in vivo.
Qiu J; Smith P; Leahy L; Thorley-Lawson DA
PLoS Pathog; 2015 Jan; 11(1):e1004561. PubMed ID: 25590614
[TBL] [Abstract][Full Text] [Related]
23. The Epstein-Barr Virus Enhancer Interaction Landscapes in Virus-Associated Cancer Cell Lines.
Ding W; Wang C; Narita Y; Wang H; Leong MML; Huang A; Liao Y; Liu X; Okuno Y; Kimura H; Gewurz B; Teng M; Jin S; Sato Y; Zhao B
J Virol; 2022 Sep; 96(18):e0073922. PubMed ID: 36094314
[TBL] [Abstract][Full Text] [Related]
24. Hairy leukoplakia: an unusual combination of transforming and permissive Epstein-Barr virus infections.
Webster-Cyriaque J; Middeldorp J; Raab-Traub N
J Virol; 2000 Aug; 74(16):7610-8. PubMed ID: 10906215
[TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr virus induces global changes in cellular mRNA isoform usage that are important for the maintenance of latency.
Homa NJ; Salinas R; Forte E; Robinson TJ; Garcia-Blanco MA; Luftig MA
J Virol; 2013 Nov; 87(22):12291-301. PubMed ID: 24027308
[TBL] [Abstract][Full Text] [Related]
26. RNA Sequencing Analyses of Gene Expression during Epstein-Barr Virus Infection of Primary B Lymphocytes.
Wang C; Li D; Zhang L; Jiang S; Liang J; Narita Y; Hou I; Zhong Q; Zheng Z; Xiao H; Gewurz BE; Teng M; Zhao B
J Virol; 2019 Jul; 93(13):. PubMed ID: 31019051
[TBL] [Abstract][Full Text] [Related]
27. Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation.
Rea D; Fourcade C; Leblond V; Rowe M; Joab I; Edelman L; Bitker MO; Gandjbakhch I; Suberbielle C; Farcet JP
Transplantation; 1994 Aug; 58(3):317-24. PubMed ID: 8053055
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA miR-BART20-5p stabilizes Epstein-Barr virus latency by directly targeting BZLF1 and BRLF1.
Jung YJ; Choi H; Kim H; Lee SK
J Virol; 2014 Aug; 88(16):9027-37. PubMed ID: 24899173
[TBL] [Abstract][Full Text] [Related]
29. The signaling pathways of Epstein-Barr virus-encoded latent membrane protein 2A (LMP2A) in latency and cancer.
Pang MF; Lin KW; Peh SC
Cell Mol Biol Lett; 2009; 14(2):222-47. PubMed ID: 19082921
[TBL] [Abstract][Full Text] [Related]
30. EBV-Encoded Latent Genes.
Kanda T
Adv Exp Med Biol; 2018; 1045():377-394. PubMed ID: 29896676
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus latent genes.
Kang MS; Kieff E
Exp Mol Med; 2015 Jan; 47(1):e131. PubMed ID: 25613728
[TBL] [Abstract][Full Text] [Related]
32. Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells.
Cahir-McFarland ED; Carter K; Rosenwald A; Giltnane JM; Henrickson SE; Staudt LM; Kieff E
J Virol; 2004 Apr; 78(8):4108-19. PubMed ID: 15047827
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency.
Hamilton-Dutoit SJ; Rea D; Raphael M; Sandvej K; Delecluse HJ; Gisselbrecht C; Marelle L; van Krieken HJ; Pallesen G
Am J Pathol; 1993 Oct; 143(4):1072-85. PubMed ID: 8214003
[TBL] [Abstract][Full Text] [Related]
34. EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency.
Riley KJ; Rabinowitz GS; Yario TA; Luna JM; Darnell RB; Steitz JA
EMBO J; 2012 May; 31(9):2207-21. PubMed ID: 22473208
[TBL] [Abstract][Full Text] [Related]
35. An EBNA3A-Mutated Epstein-Barr Virus Retains the Capacity for Lymphomagenesis in a Cord Blood-Humanized Mouse Model.
Romero-Masters JC; Ohashi M; Djavadian R; Eichelberg MR; Hayes M; Zumwalde NA; Bristol JA; Nelson SE; Ma S; Ranheim EA; Gumperz JE; Johannsen EC; Kenney SC
J Virol; 2020 May; 94(10):. PubMed ID: 32132242
[TBL] [Abstract][Full Text] [Related]
36. Upregulation of Epstein-Barr virus-encoded latent membrane protein by human herpesvirus 6 superinfection of EBV-carrying Burkitt lymphoma cells.
Cuomo L; Trivedi P; de Grazia U; Calogero A; D'Onofrio M; Yang W; Frati L; Faggioni A; Rymo L; Ragona G
J Med Virol; 1998 Jul; 55(3):219-26. PubMed ID: 9624610
[TBL] [Abstract][Full Text] [Related]
37. Differential regulation of Epstein-Barr virus (EBV) latent gene expression in Burkitt lymphoma cells infected with a recombinant EBV strain.
Trivedi P; Spinsanti P; Cuomo L; Volpe M; Takada K; Frati L; Faggioni A
J Virol; 2001 May; 75(10):4929-35. PubMed ID: 11312367
[TBL] [Abstract][Full Text] [Related]
38. The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell.
Babcock GJ; Hochberg D; Thorley-Lawson AD
Immunity; 2000 Oct; 13(4):497-506. PubMed ID: 11070168
[TBL] [Abstract][Full Text] [Related]
39. Genomic Landscapes of Epstein-Barr Virus in Pulmonary Lymphoepithelioma-Like Carcinoma.
Wu YX; Zhang WL; Wang TM; Liao Y; Zhang YJ; Xiao RW; Jia YJ; Wu ZY; Deng CM; Yang DW; Xue WQ; He YQ; Zheng XH; Li XZ; Zhou T; Zhang PF; Zhang SD; Hu YZ; Zhang JB; Jia WH
J Virol; 2022 Feb; 96(4):e0169321. PubMed ID: 34908446
[TBL] [Abstract][Full Text] [Related]
40. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K
J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
